Erasca Correlations
ERAS Stock | USD 1.48 0.04 2.78% |
The current 90-days correlation between Erasca Inc and Keros Therapeutics is 0.21 (i.e., Modest diversification). The correlation of Erasca is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Erasca Correlation With Market
Modest diversification
The correlation between Erasca Inc and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and DJI in the same portfolio, assuming nothing else is changed.
Erasca |
Moving together with Erasca Stock
0.79 | ME | 23Andme Holding | PairCorr |
0.78 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
0.93 | VERA | Vera Therapeutics | PairCorr |
0.64 | CDIOW | Cardio Diagnostics | PairCorr |
0.79 | DSGN | Design Therapeutics | PairCorr |
0.93 | VINC | Vincerx Pharma Earnings Call Next Week | PairCorr |
0.95 | VKTX | Viking Therapeutics | PairCorr |
0.74 | DYAI | Dyadic International Earnings Call This Week | PairCorr |
0.81 | VRDN | Viridian Therapeutics | PairCorr |
0.79 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.86 | VTRS | Viatris | PairCorr |
0.94 | VTYX | Ventyx Biosciences | PairCorr |
Moving against Erasca Stock
0.86 | VALN | Valneva SE ADR | PairCorr |
0.71 | VIGL | Vigil Neuroscience | PairCorr |
0.65 | DMAC | DiaMedica Therapeutics | PairCorr |
0.57 | DVAX | Dynavax Technologies | PairCorr |
0.48 | EQ | Equillium | PairCorr |
0.41 | VERV | Verve Therapeutics | PairCorr |
0.35 | DTIL | Precision BioSciences Earnings Call This Week | PairCorr |
0.94 | VRNA | Verona Pharma PLC | PairCorr |
0.7 | VRTX | Vertex Pharmaceuticals | PairCorr |
0.61 | EDSA | Edesa Biotech | PairCorr |
0.59 | VTVT | vTv Therapeutics | PairCorr |
0.58 | SRZNW | Surrozen Warrant | PairCorr |
0.52 | VSTM | Verastem | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Erasca Stock performing well and Erasca Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Erasca's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
IPSC | 2.96 | (1.08) | 0.00 | (0.74) | 0.00 | 5.88 | 17.02 | |||
NGM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
KROS | 4.01 | (1.73) | 0.00 | (274.04) | 0.00 | 4.41 | 76.68 | |||
GLUE | 3.51 | (0.31) | 0.00 | (0.33) | 0.00 | 7.34 | 19.92 | |||
GRCL | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
THRX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
DSGN | 4.48 | (0.24) | 0.00 | (0.44) | 0.00 | 9.45 | 26.51 | |||
EWTX | 2.88 | 0.06 | 0.00 | (0.05) | 0.00 | 5.32 | 26.44 | |||
CCCC | 3.52 | (0.77) | 0.00 | (0.41) | 0.00 | 7.10 | 20.72 | |||
MLYS | 4.27 | 0.28 | 0.11 | (0.25) | 4.47 | 10.04 | 50.53 |
Erasca Corporate Management
Michael Varney | Scientific Development | Profile | |
Lisa TesvichBonora | Chief Officer | Profile | |
Nik Chetwyn | VP Operations | Profile | |
CPA MS | VP Fin | Profile | |
Wei MD | Chief Officer | Profile | |
JD Esq | General Secretary | Profile | |
Esq JD | General Secretary | Profile |